Stay informed with the latest updates, our articles and expert perspectives.
Explore Sulzer’s latest news, industry insights. Discover innovations, project highlights, and expert commentary designed to keep you ahead in a rapidly evolving market.
Introduction - the business case for thermal pretreatment BioFlux™ improves both OPEX and product margins by tackling the two biggest SAF cost drivers: feedstock price and hydrogen consumption. It enables use of lower-cost FOGs and reduces hydrotreating hydrogen demand by up to 50% through oxygen removal. Combined benefits translate to up to 12% lower production costs vs. conventional processes, and up to 15% savings when compared to the combined conventional pretreatment + h
